FDA clearance received for CADD-Sentry Pro Medication Safety Software
SMITHS Medical, part of the global technology business Smiths Group, today announces it has received 510(k) clearance from the US Food and Drug Administration (FDA) for new medication safety software that makes programming pain management infusion pumps simpler and safer.
Infusion pumps allow doctors to control precisely the amount of medication given to patients.
The CADD-Sentry Pro Medication Safety Software reduces the risk of errors by enabling medical professionals to enter standardised pain therapy protocols onto a secure database on the hospital computer network and then download them into a pump. Previously clinicians have had to program each pump individually.
Srini Seshadri, Group Managing Director of Smiths Medical, said: The new CADD-Sentry Pro Medication Safety Software demonstrates our continued commitment to developing safe infusion systems for hospitals.
"When used with the CADD-Prizm PCS II ambulatory infusion pump, the CADD-Sentry Pro software will significantly improve patient safety and clinician confidence. "
The software has two applications: the Administrator software which enters, manages and stores therapy protocols in a secure database on the hospital computer network and the Point of Care software which accesses and downloads the protocols into a CADD-Prizm PCS II ambulatory infusion pump.
The Point of Care software incorporates additional safety features, including bar code verification to ensure the patient receives the right medication and another verification feature that ensures a second nurse reviews the pump program before starting an infusion.